Related references
Note: Only part of the references are listed.Paraneoplastic Thrombocytosis in Ovarian Cancer
Rebecca L. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer
Michael J. Silverberg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
B-Cell Stimulatory Cytokines and Markers of Immune Activation Are Elevated Several Years Prior to the Diagnosis of Systemic AIDS-Associated Non-Hodgkin B-Cell Lymphoma
Elizabeth Crabb Breen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy
Anouk Kesselring et al.
CLINICAL INFECTIOUS DISEASES (2011)
A dual role for the immune response in a mouse model of inflammation-associated lung cancer
Michael Dougan et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
Sharon R. Pine et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Cancer Burden in the HIV-Infected Population in the United States
Meredith S. Shiels et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
HIV, cancer, and aging
Andrew E. Grulich et al.
SEXUAL HEALTH (2011)
C-Reactive Protein and Risk of Lung Cancer
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Jacqueline Neuhaus et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV infection and the risk of cancers with and without a known infectious cause
Michael J. Silverberg et al.
AIDS (2009)
Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression
Roger J. Bedimo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Kristine H. Allin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
Marguerite Guiguet et al.
LANCET ONCOLOGY (2009)
Interleukin-2 Therapy in Patients with HIV Infection
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Incidence of types of cancer among HIV-Infected persons compared with the general population in the United States, 1992-2003
Pragna Patel et al.
ANNALS OF INTERNAL MEDICINE (2008)
AIDS-related malignancies: State of the art and therapeutic challenges
Jean-Philippe Spano et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
Risk of cancers during interrupted antiretroviral therapy in the SMART study
Michael J. Silverberg et al.
AIDS (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
C-reactive protein levels, variation in the c-reactive protein gene, and cancer risk: The Rotterdam Study
Claire Siemes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer
George Theodoropoulos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Obesity, adipokines, and prostate cancer in a prospective population-based study
Jacques Baillargeon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Interleukin-6 polymorphisms and the risk of cervical cancer
N. C. Nogueira de Souza et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort
D Il'yasova et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Share Paper
